Evidence map›Paper›PMID 34227737›Full record

ReviewMolecular plant pathology2021

Cassava diseases caused by Xanthomonas phaseoli pv. manihotis and Xanthomonas cassavae.

Carlos A Zárate-Chaves, Diana Gómez de la Cruz, Valérie Verdier, Camilo E López, Adriana Bernal, Boris Szurek

Open access · goldAbstract readReview
In one paragraph

Review in Molecular plant pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Pathogens (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Frontiers in plant science · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Carlos A Zárate-ChavesPHIM, Université Montpellier, CIRAD, INRAe, IRD, Institut Agro, Montpellier, France.
Diana Gómez de la CruzThe Sainsbury Laboratory, University of East Anglia, Norwich, UK.
Valérie VerdierPHIM, Université Montpellier, CIRAD, INRAe, IRD, Institut Agro, Montpellier, France.
Camilo E LópezManihot Biotec, Departamento de Biología, Universidad Nacional de Colombia, Bogotá, Colombia.
Adriana BernalLaboratorio de Interacciones Moleculares de Microorganismos Agrícolas, Departamento de Ciencias Básicas, Universidad de los Andes, Bogotá, Colombia.
Boris SzurekPHIM, Université Montpellier, CIRAD, INRAe, IRD, Institut Agro, Montpellier, France.ORCID 0000-0002-1808-7082
Centre de Coopération Internationale en Recherche Agronomique pour le Développement · FRUniversidad de Los Andes · COUniversidad Nacional de Colombia · COUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xanthomonas phaseoli pv. manihotis (Xpm) and X. cassavae (Xc) are two bacterial pathogens attacking cassava. Cassava bacterial blight (CBB) is a systemic disease caused by Xpm, which might have dramatic effects on plant growth and crop production. Cassava bacterial necrosis is a nonvascular disease caused by Xc with foliar symptoms similar to CBB, but its impacts on the plant vigour and the crop are limited. In this review, we describe the epidemiology and ecology of the two pathogens, the impacts and management of the diseases, and the main research achievements for each pathosystem. Because Xc data are sparse, our main focus is on Xpm and CBB.

Indexed as

ManihotXanthomonasPlant Diseasescassavacassava bacterial blightcassava bacterial necrosisquantitative resistanceXanthomonas

Identifiers

PMID34227737
PMCPMC8578842
OpenAlexW3177645065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.